Myeloma Survival Rates
Below are the five-year survival rates for multiple myeloma patients treated by Seattle Cancer Care Alliance compared to patients who were treated for myeloma elsewhere. This information was collected by the National Cancer Data Base for patients who were treated between 1998 and 2002 and followed for five years.
- SCCA patients are represented by the red line. Their five-year survival rate was 49 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care at SCCA are included.
- Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by blue, green, and yellow lines. Their five-year survival rates were between 25 and 36 percent.